Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Management of Chronic Lymph Node Enlargement

Initial Evaluation

  • A thorough history should include previous lymphoid neoplasms, B-symptoms, and immunosuppression status, as recommended by the American Society of Hematology 1
  • Presence of hepatosplenomegaly should be assessed during physical examination, according to the American Society of Hematology 1

Laboratory Investigations

  • Complete blood count with differential is recommended for initial evaluation, as suggested by the American Society of Hematology 1
  • Blood chemistry including lactate dehydrogenase (LDH) is recommended for initial evaluation, according to the American Society of Hematology 1
  • Flow cytometry is recommended for suspected hematologic malignancies, as suggested by the International Society of Hematology 3

Imaging Studies

  • CT scan should be considered for persistent lymphadenopathy or when malignancy is suspected, as recommended by the American College of Radiology 2
  • PET/CT may be useful for suspected lymphoma with sensitivity of 88% and specificity of 98%, according to the American Urological Association 4
  • CT is the imaging method of choice for mediastinal lymphadenopathy, with size criteria (>15 mm short axis) guiding management decisions, as recommended by the American College of Radiology 2
  • MRI may be superior for evaluating chest wall involvement and superior sulcus tumors, according to the European Respiratory Society 5

Biopsy Considerations

  • Ultrasound-guided FNAC has 93% sensitivity and 91% specificity for palpable nodes, as reported by the American Urological Association 4
  • Excisional biopsy should be considered when FNAC is non-diagnostic or lymphoma is suspected, as recommended by the European Hematology Association 6, 7

Disease-Specific Management

  • For diffuse large B-cell lymphoma, response assessment should follow standardized criteria evaluating lymph node size regression, as recommended by the European Hematology Association 6, 7, 8
  • For chronic lymphocytic leukemia/small lymphocytic lymphoma, CT scans are desirable for evaluation of adenopathy, and response criteria include at least 50% reduction in lymphadenopathy for partial response, as recommended by the National Comprehensive Cancer Network 9

Common Pitfalls and Caveats

  • Enlarged lymph nodes may be reactive rather than neoplastic, and normal-sized nodes may contain malignant cells, as noted by the American College of Radiology 2
  • Morphological criteria beyond size improve diagnostic accuracy, according to the American College of Radiology 2

REFERENCES

9

chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2015